HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients
Article in Frontiers in Immunology (July 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (July 2024)
Article in Cancer Medicine (June 2024)
Article in Frontiers in Oncology (January 2024)